John P. Saharek - CEO of ImprimisRx at Harrow, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO of ImprimisRx
Stock Symbol
HROW, HROWL, HROWM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John P. Saharek since 11/5/2023

Holdings reported by John P. Saharek for Harrow, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 300K $12.4M $41.37 Sep 11, 2024 Direct
RSU 0 Feb 20, 2024 Direct Common Stock
Stock Option (Right to Buy) 0 Sep 11, 2024 Direct Common Stock

Transactions reported by John P. Saharek for Harrow, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.